Ab Biodisk

Ab Biodisk specialises in antimicrobial susceptibility testing products. These include the ETEST series of strips for antibiotics like trovafloxacin, vancomycin, and benzylpenicillin, as well as dedicated systems such as the U3 for tetracycline and trimethoprim/sulfamethoxazole. The company also offers ESBL detection strips and variants for anaerobic bacteria testing. These devices help clinical microbiology labs identify bacterial resistance profiles.

Ab Biodisk is based in the United States. Since the company operates within the US, its devices are subject to FDA oversight. The company’s products fall under Class II medical devices, which require premarket notification (510(k)) clearance before they can be marketed in the US. This classification reflects moderate risk, requiring validation of safety and performance before commercialisation.

Ab Biodisk’s devices are listed in the FDA’s 510(k) clearance registry. This registry documents premarket submissions for Class II devices, confirming that each product has undergone the required review process to demonstrate substantial equivalence to a legally marketed predicate device. The listing serves as public evidence of regulatory clearance for these antimicrobial testing systems.

All of Ab Biodisk’s devices are classified as Class II medical devices. This classification is determined by the FDA based on factors like the device’s intended use, potential risks, and benefits. Class II devices require special controls beyond general controls to ensure safety and effectiveness, such as performance standards or post-market surveillance. In this case, the company’s antimicrobial susceptibility testing strips and systems meet these criteria due to their role in critical clinical decision-making.